Tetraphase Pharmaceuticals to Present at BMO Prescriptions for Success in Healthcare Conference 2017
-
Tetraphase Pharma (TTPH) Reports $60M Offering of Common Stock
-
Tetraphase Announces Proposed Public Offering of Common Stock
-
Tetraphase Pharmaceuticals (TTPH) PT Raised to $13 at BMO Capital
-
Tetraphase Pharma (TTPH) Climbs 17% Following BMO Capital Upgrade to Outperform
-
BMO Capital Upgrades Tetraphase Pharmaceuticals (TTPH) to Outperform
-
BMO Capital Starts Tetraphase Pharmaceuticals (TTPH) at Market Perform
-
Streetinsider.com's Hot Lunchtime Reads 4/15: (ANF) (PLUG) (TTPH) (CLSN)
-
Tetraphase Pharmaceuticals (TTPH) ECCMID Abstracts Support Eravacycline Differentiation in cIAI and cUTI, BMO Capital Says
-
Tetraphase Pharma (TTPH) Closes 4.95M Common Offering for Proceeds of $173.1M
-
Tetraphase Pharmaceuticals Announces Closing of Public Offering of Common Stock
-
Tetraphase Pharma (TTPH) Prices Larger 4.3M Common Offering at $35/Share
-
Tetraphase Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Tetraphase Pharma (TTPH) Announces 3.5M Common Offering
-
Tetraphase Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Tetraphase Pharmaceuticals (TTPH) PT Raised to $48 at BMO Capital
-
Tetraphase Pharma (TTPH) Prices 3.95M Common Offering at $19/Share
-
Tetraphase Pharma (TTPH) to Offer $75M in Stock
-
Tetraphase Pharmaceuticals (TTPH) Higher on Trial Results; PT More than Doubled at BMO Capital
-
Tetraphase Pharma (TTPH) Announces 3.3M Common Stock Offering
-
Notable Analyst Rating Changes 04/15: (JCP) (CMG) (UA) Upgraded; (UNTK) (ABX) (PAAS) Downgraded
-
BMO Capital Starts Tetraphase Pharmaceuticals (TTPH) at Outperform
-
Tetraphase Pharmaceuticals (TTPH) IPO Opens, Trades Flat
-
Tetraphase (TTPH) Prices 10.7M IPO at $7/Share